# IVERMECTIN
> **ANDA210225** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2020-04-13
## Drug
- **FDA Application Number:** ANDA210225
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IVERMECTIN
- **Generic name:** IVERMECTIN
- **Active ingredients:** IVERMECTIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2020-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210225)
---
*MORVS · CC0 1.0*